Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ezetimibe, Simvastatin, and Vytorin on L5 in Metabolic Syndrome
NCT00988364Phase 4Completed
- Sponsor
- Baylor College of Medicine
- Start
- Mar 2007
- Primary completion
- Feb 2008
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, simvastatin, Vytorin in atherosclerosis, sponsored by Baylor College of Medicine. Started Mar 2007; status: completed.
02
Drugs
ezetimibesimvastatinVytorin
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00988364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988364.